REQUEST A DEMO
Total
USD $0.00
Search more companies

Crescent Formulations Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Crescent Formulations Private Limited Profile Updated: May 20, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Crescent Formulations Private Limited is an unlisted company, incorporated on 28/10/2010. It has its registered office in the State of Telangana, India. Company's corporate identification number (CIN) is U24232TG2010PTC070991 and registration number is 070991. The company is a trade company, it is engaged in wholesale trading.

Legal Address
4-7-11/4/C, Crescent Towers Raghavendra Nagar, Nacharam
Rangareddy; Andhra Pradesh; Postal Code: 500076

Contact Details: Purchase the Crescent Formulations Private Limited report to view the information.

Basic Information
Total Employees:
Purchase the Crescent Formulations Private Limited report to view the information.
Outstanding Shares:
Purchase the Crescent Formulations Private Limited report to view the information.
Registered Capital:
Purchase the Crescent Formulations Private Limited report to view the information.
Incorporation Date:
October 28, 2010
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Company Performance
Financial values in the chart are available after Crescent Formulations Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
-5.49%
Total operating revenue
-5.2%
Operating profit (EBIT)
-35.25%
EBITDA
-28.09%
Net Profit (Loss) for the Period
-29.57%
Total assets
42.04%
Total equity
10.69%
Operating Profit Margin (ROS)
-1.98%
Net Profit Margin
-1.18%
Return on Equity (ROE)
-5.52%
Debt to Equity Ratio
56.97%
Quick Ratio
-0.66%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?